Ignite Creation Date:
2024-05-05 @ 5:01 PM
Last Modification Date:
2024-10-26 @ 9:26 AM
Study NCT ID:
NCT00362466
Status:
TERMINATED
Last Update Posted:
2009-11-20
First Post:
2006-08-09
Brief Title:
A Study of Dasatinib vs High-Dose Imatinib 600 mg in Patients With Chronic Phase Chronic Myeloid Leukemia CML Who Failed to Achieve Complete Cytogenetic Response After 3-18 Months of Imatinib Therapy
Sponsor:
Bristol-Myers Squibb
Organization:
Bristol-Myers Squibb
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Leukemia |
Keywords:
| Name | View |
|---|---|
| Leukemia chronic myeloid leukemia - chronic phase | View |